Article Text

Download PDFPDF

383 Changes in the proteome of cervicovaginal fluid during HPV infection in hpv-vaccinated women
Free
  1. Mariia Iurova1,
  2. Nataliia Starodubtseva2,
  3. Kirill Gusakov2,
  4. Niso Nazarova2,
  5. Anna Bugrova3,
  6. Alexandr Brzhozovzkiy2 and
  7. Vladimir Frankevich2
  1. 1Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Federal State Budget Institution ‘national Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov’ Ministry of Health of Russia
  2. 2Federal State Budget Institution ‘national Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov’ Ministry of Health of Russia
  3. 3Federal State Budget Institution ‘national Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov’ Ministry of Health of Russia; N.M. Emanuel Institute of Biochemical Physics of Ras, Moscow, Russian Federation

Abstract

Methodology This study was approved by the Institute Research Medical Ethics Committee. The study involved 62 patients vaccinated against HPV, aged 19 to 45 years. The patients were divided into 2 groups: group 1 - HPV-positive (n = 14) and group 2 - HPV-negative (n = 48). CVF proteomic analysis was carried out by the bottom-up method (HPLC-MS/MS) on an Agilent 1100/7 Tl LTQ-FT Ultra mass spectrometer (Thermo Electron, Germany). The search for protein identification and semiquantitative analysis was carried out against the UniProt Knowledgebase (UniProtKB, version 16.05.2014) using the MaxQuant software, version 1.1.1.2.

Results None of the vaccinated women showed cervical pathology by cytology. In 6 cases, a biopsy of the cervix was performed in the presence of HPV carcinogenic risk together with mild changes in the cervix epithelium during colposcopy. The histological diagnosis in all cases (n = 6) corresponded to CIN1.

In total, more than 419 different proteins were detected in CVF samples. The level of 34 CVF proteins were significantly different in HPV positive group compared to HPV negative patients (p<0.05). Among them, 9 proteins were involved in the innate immunity processes (APOB, FABP5, GRN, HP, MUC5AC, OLFM4, PKP1, QSOX1, S100A8).

Conclusion A high incidence of HPV was revealed in Russian women previously vaccinated against HPV (23%). CIN 1 was detected in 6 HPV-positive vaccinated women (43%) with normal cytology (NILM). Proteomic analysis of CVF can be proposed as a non-invasive method for detecting biomarkers for early diagnosis of CIN. This work was supported by RSF grant No. 18-75-10097.

Disclosures Nothing to disclose.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.